Clinical Trial Update: A Study of the Effects of PEITC on Oral Cells With Mutant p53 [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluated the effects of phenethyl isothiocyanate (PEITC) on oral cells with mutant p53 in the context of oral cancer; the trial has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Cancer

Drugs mentioned

• PEITC (phenethyl isothiocyanate)

Snippet

Sponsor: Georgetown University | Conditions: Oral Cancer | Phase 1, Phase 2 | Status: COMPLETED